Understanding Clinical Trials for Alzheimer’s Medications

VOS Community Room | Monday, September 22 | 1–2 PM
Sponsored by the Brain Health Group

We’re pleased to welcome back Dr. Carol Van Hulle, Department of Medicine, School of Medicine and Public Health, University of Wisconsin–Madison.

In April, Dr. Van Hulle introduced us to the pathology that leads to Alzheimer’s disease. This follow-up presentation will build on that discussion, focusing on the role of clinical trials in developing new medications.

Dr. Van Hulle will share insights and answer key questions such as:

• What exactly is a clinical trial?

• Why are clinical trials considered the “gold standard” for approving new medications?

• Are all clinical trials the same?

• How do I know if participating in a clinical trial is right for me?

This is a valuable opportunity to expand your understanding of Alzheimer’s research and the part you or your loved ones may play in advancing care.

Everyone is Welcome!

Registration is appreciated, but not required.

Questions or to register: Contact Jen Graf, Senior Director of Dementia Programming, at jgraf@threepillars.org or call 262.965.7133.